Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants Mylan Ireland Limited and Egis Pharmaceuticals PLC against the decision of the State Institute for Drug Control from 30. 3. 2020, under the no.: SUKLS174857/2017:

• the decision is partially reversed and the proceedings are terminated  
• the appeal is dismissed and the decision under appeal is partially upheld.

More information: MZCR.cz.